To study the effect of TSG methylation on the outcomes of the conservative treatment of patients with endometrioid adenocarcinoma, eight genes generally acknowledged as TSGs were initially selected: P16, APC, CDH13, SEPTIN9, PITX2, SHOX2, CDO1, and PTEN. This evidence concerns the gene SHOX2 and endometrioid adenocarcinoma.